Bio-Rad Laboratories (BIO) Q2 2024 Earnings
BIO·Reported August 1, 2024·After market close
Bio-Rad Laboratories reported Q2 2024 revenue of $638.5M, missed analyst consensus of $645.8M by $7.3M. Diluted EPS came in at $3.11, beat the $2.12 consensus by $0.99.
Revenue
$638.5Mmissed by $7.3M
Consensus: $645.8MDiluted EPS
$3.11beat by $0.99
Consensus: $2.12
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Bio-Rad Laboratories's Q2 2024 earnings report.
Bio-Rad Laboratories (BIO) reported Q2 2024 earnings on August 1, 2024 after market close.
Bio-Rad Laboratories reported revenue of $638.5M and diluted EPS of $3.11 for Q2 2024.
Revenue missed the consensus estimate of $645.8M by $7.3M. EPS beat the consensus estimate of $2.12 by $0.99.
You can read the 10-Q periodic report (0000012208-24-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.